How Jane Pangbourne’s Bestselling Book, I Choose Menopause, Is Helping To Rewrite The HRT Story

On The Table Read Magazine, “the best arts and entertainment magazine UK“, as the US FDA finally scraps outdated HRT warnings based on 20-year-old misinformation, bestselling author Jane Pangbourne’s empowering book I Choose Menopause: Love Your Hormones & HRT is leading the charge to end the fear, reclaim women’s health, and prove that modern hormone therapy can be safe and life-changing.

From Personal Struggle to National Influence

Jane Pangbourne, the author of the No.1 bestselling book I Choose Menopause: Love Your Hormones & HRT, began her menopause journey at just 37 with premature ovarian insufficiency. Dismissed by the medical system for years, she took matters into her own hands, researched extensively, and turned her experience into a mission. Today, the Market Harborough entrepreneur and Level 6 certificated women’s health practitioner runs the thriving Menopausal Not Mad community and is recognised as one of the UK’s Top 30 menopause influencers for 2025.

A Decade-Long Fight Against Misinformation

For over ten years Pangbourne has faced relentless online trolling and hate mail simply for stating that modern, regulated body-identical HRT is safe and life-changing for most women when correctly prescribed. Her core message — that the risks have been vastly overstated due to misinterpreted data from two decades ago — is now being vindicated across the Atlantic.

The US Food and Drug Administration has announced it will strip cautionary labels from more than 20 hormone therapy products that previously warned of risks of heart attack, stroke, and dementia. These warnings, in place for over 20 years, have officially been acknowledged as based on outdated and inaccurate information. Campaigners like Pangbourne, who have consistently highlighted the misinterpretation of the original studies, are celebrating the decision as a major step forward.

While welcoming the FDA move, Pangbourne is urging British health authorities to follow suit quickly. She argues that UK patient information leaflets and some medical guidance still reflect the same old fears, leaving women confused and too frightened to consider treatment that could transform their quality of life.

Countering the Latest Wave of HRT Scare Stories

The FDA announcement came in the same week that television presenter Davina McCall revealed her breast cancer diagnosis, triggering another round of headlines and social media posts attempting to link HRT with the disease. Pangbourne immediately pushed back, stressing that regulated body-identical HRT shows no proven connection to breast cancer. She points out that any small increased risk associated with older synthetic progestogens remains far lower than risks from regular alcohol consumption, smoking, or inactivity — and that more women die from heart disease than breast cancer.

To further dismantle lingering myths, Pangbourne is launching a new social media series inviting breast cancer survivors who have safely used HRT to tell their stories. She believes real-life experiences will help reassure women and demonstrate that regulated HRT and breast cancer are not inherently linked.

The Book That Started Conversations That Matter

At the heart of Pangbourne’s work is her practical, positive guide I Choose Menopause. Recently launched in paperback, the book challenges widespread myths, offers clear evidence-based information, and provides hope for anyone feeling exhausted, emotional, or lost during perimenopause and menopause. At a recent appearance at The Big Festoon personal-development festival she gave away almost 200 copies to women who approached her in tears, grateful finally to feel heard.

Building Hope for Everyone

Recommended by doctors and healthcare professionals, Pangbourne has gathered over 55,000 petition signatures for better GP menopause training and built one of the most engaged online menopause communities worldwide. An active ally to the LGBTQIA+ community, she is determined that reliable, fear-free information reaches every person who needs it — regardless of gender identity or background.

With the US now correcting two decades of cautionary labelling, the author of I Choose Menopause is calling on the UK to act swiftly so that women here can finally access treatment without the shadow of outdated fear. As she puts it, no one should have fluctuating or missing hormones dictate their quality of life.

Find more from Jane Pangbourne now:

Kindle: https://amzn.to/48xMRq1

Paperback: https://amzn.to/3YxA9nH

Hardcover: https://amzn.to/40dWDuX

Facebook